Sutter Hill Ventures
About UsTeamPortfolioNews
Networking & Computer Technology
Business & Financial Services
Healthcare
Software
Consumer
Investment Partnerships

Amylin Pharmaceuticals, Inc. is engaged in the discovery and development of potential drug candidates for the treatment of metabolic disorders. The Company is developing SYMLIN for the treatment of people with diabetes who use insulin.

.
.
Acceleron AkaRx Aksys
AmeriGroup Ameritox Amira
Amylin Pharmaceuticals Aspect Medical Systems Barrx
BRP - Blue Ridge Pharmaceutical Cardica Cor
Corcept Corixa Curis
Dionex Drais Horizon
Hybritech IBalance Idexx
Idun InfoMedics Interventional Technologies
Isis Pharmaceuticals Kalypto Medical Lifescan
Macusight Metronome Molecular Devices
Naryx Neurex NuGEN
Omnicell.com pacificbiosciences.com Portola Pharmaceutical
Pyxis Restoration Robotics Roxro Pharma
Threshold Pharmaceuticals Verinata Health Vical
Virobay Xoft microTube